Skip to main content

Table 1 Cell viabilities in the presence of bare nanocomposites following irradiation

From: Development of Fe3O4 core–TiO2 shell nanocomposites and nanoconjugates as a foundation for neuroblastoma radiosensitization

Fe3O4@TiO2

0 nM

100 nM

250 nM

SK-N-AS

0 Gy

100 ± 2.22

100 ± 2.00

100 ± 1.42

2 Gy

88.15 ± 2.85

88.10 ± 3.60

82.22 ± 2.50**

5 Gy

60.00 ± 1.63

59.61 ± 1.73

50.30 ± 4.49**

10 Gy

38.90 ± 3.16

38.40 ± 4.53

32.35 ± 2.49**

SK-N-DZ

0 Gy

100 ± 7.42

100 ± 9.29

100 ± 1.86

2 Gy

78.68 ± 2.70

77.00 ± 3.18

74.55 ± 3.18

5 Gy

52.13 ± 2.46

51.35 ± 2.47

46.89 ± 1.64**

10 Gy

31.14 ± 2.78

29.01 ± 3.53

25.03 ± 2.05**

  1. Table of cell viabilities (expressed as % of non-irradiated treatment control for a given concentration of nanoconjugates, after adjustment for baseline cytotoxicity) for SK-N-AS and SK-N-DZ cells treated with varying concentrations of bare nanocomposites and different doses of ionizing radiation (Fig. 5). Entries contain mean ± SD. **: < 0.01 significance level, *** < 0.001 significance level.
Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us